TENOFOVIR DISOPROXIL
tenofovir disoproxil fumarate 300 mg tablet, 30
TENOFOVIR DISOPROXIL (10310P)
10310P
Manner of administration:Oral
Restriction 6998
Indication: HIV infection
Treatment phase: Initial
Restriction 6982
Indication: HIV infection
Treatment phase: Continuing
Restriction 6980
Indication: Chronic hepatitis B infection
Restriction 6992
Indication: Chronic hepatitis B infection
Restriction 6983
Indication: Chronic hepatitis B infection
Restriction 6984
Indication: Chronic hepatitis B infection
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 2 | Max qty units: 60 | # of repeats: 5 | DPMQ: $126.48 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
|
|
|||||
|
|
|||||